| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden;
Cancer Center Karolinska, Karolinska Hospital, Stockholm, Sweden; and
Laboratory Di Immunochimica, DIBIT, H.S. Raffaele, Milan, Italy
NK cell-mediated effector functions are regulated by a delicate balance between positive and negative signals. Receptors transmitting negative signals upon engagement with target cell MHC class I molecules have been characterized in detail in recent years. In contrast, less information is available about receptor-ligand interactions involved in the transmission of positive or "triggering" signals to NK cells. Recently, it has been described that murine NK cells are triggered by the costimulatory molecules CD80, CD86, and CD40. Using NK cell lines derived from PBMC as effectors, we demonstrate that the human CD80 and CD86 gene products can function as triggering molecules for NK cell-mediated cytotoxicity. Expression of human CD80 or CD86 molecules in murine B16.F1 melanoma cells rendered these significantly more susceptible to lysis by human NK cell lines. Blocking of the transfected gene products with specific mAb reduced lysis levels to that of nontransfected control cell lines. Triggering of human NK cells by CD80 and CD86 appeared to be independent of CD28 and CTLA-4, at least as determined by the reagents used in the present study, because the expression of these molecules could not be detected on the NK cell lines by either flow cytometry or in redirected lysis assays. Thus, human NK cells may use receptors other than CD28 and CTLA-4 in their interactions with CD80 and CD86 molecules. Alternatively, interactions may involve variants of CD28 (and possibly CTLA-4) that are not recognized by certain anti-CD28 mAb.
This article has been cited by other articles:
|
|
 |
|
  A. Kruschinski, A. Moosmann, I. Poschke, H. Norell, M. Chmielewski, B. Seliger, R. Kiessling, T. Blankenstein, H. Abken, and J. Charo Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas PNAS, November 11, 2008; 105(45): 17481 - 17486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Pegram, J. T. Jackson, M. J. Smyth, M. H. Kershaw, and P. K. Darcy Adoptive Transfer of Gene-Modified Primary NK Cells Can Specifically Inhibit Tumor Progression In Vivo J. Immunol., September 1, 2008; 181(5): 3449 - 3455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Achdout, I. Manaster, and O. Mandelboim Influenza Virus Infection Augments NK Cell Inhibition through Reorganization of Major Histocompatibility Complex Class I Proteins J. Virol., August 15, 2008; 82(16): 8030 - 8037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shanker, G. Verdeil, M. Buferne, E.-M. Inderberg-Suso, D. Puthier, F. Joly, C. Nguyen, L. Leserman, N. Auphan-Anezin, and A.-M. Schmitt-Verhulst CD8 T Cell Help for Innate Antitumor Immunity J. Immunol., November 15, 2007; 179(10): 6651 - 6662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, D. S. J. Allan, K. Krzewski, B. Ge, H. Kopcow, and J. L. Strominger CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells PNAS, July 5, 2006; 103(27): 10346 - 10351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-X. Gao, X. Liu, J. Wen, M. A. Caligiuri, I. Stroynowski, P. Zheng, and Y. Liu Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells Blood, December 15, 2003; 102(13): 4456 - 4463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Mailliard, Y.-I. Son, R. Redlinger, P. T. Coates, A. Giermasz, P. A. Morel, W. J. Storkus, and P. Kalinski Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function J. Immunol., September 1, 2003; 171(5): 2366 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Geldhof, J. A. Van Ginderachter, Y. Liu, W. Noel, G. Raes, and P. De Baetselier Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation Blood, December 1, 2002; 100(12): 4049 - 4058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Terrazzano, D. Zanzi, C. Palomba, E. Carbone, S. Grimaldi, S. Pisanti, S. Fontana, S. Zappacosta, and G. Ruggiero Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-{gamma} production by human natural killer effectors J. Leukoc. Biol., August 1, 2002; 72(2): 305 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pisegna, A. Zingoni, G. Pirozzi, B. Cinque, M. G. Cifone, S. Morrone, M. Piccoli, L. Frati, G. Palmieri, and A. Santoni Src-Dependent Syk Activation Controls CD69-Mediated Signaling and Function on Human NK Cells J. Immunol., July 1, 2002; 169(1): 68 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Haller, P. Serrant, D. Granato, E. J. Schiffrin, and S. Blum Activation of Human NK Cells by Staphylococci and Lactobacilli Requires Cell Contact-Dependent Costimulation by Autologous Monocytes Clin. Vaccine Immunol., May 1, 2002; 9(3): 649 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Kelly, K. Takeda, P. K. Darcy, H. Yagita, and M. J. Smyth A Role for IFN-{gamma} in Primary and Secondary Immunity Generated by NK Cell-Sensitive Tumor-Expressing CD80 In Vivo J. Immunol., May 1, 2002; 168(9): 4472 - 4479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Costa, D. F. Barber, and W. L. Fodor Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells J. Immunol., April 15, 2002; 168(8): 3808 - 3816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ferlazzo, C. Semino, G. M. Spaggiari, M. Meta, M. C. Mingari, and G. Melioli Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates Int. Immunol., December 1, 2000; 12(12): 1741 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Blackstock, N. McElwee, E. Neller, and J. Shaddix-White Regulation of Cytokine Expression in Mice Immunized with Cryptococcal Polysaccharide, a Glucuronoxylomannan (GXM), Associated with Peritoneal Antigen-Presenting Cells (APC): Requirements for GXM, APC Activation, and Interleukin-12 Infect. Immun., September 1, 2000; 68(9): 5146 - 5153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Goodier and M. Londei Lipopolysaccharide Stimulates the Proliferation of Human CD56+CD3- NK Cells: A Regulatory Role of Monocytes and IL-10 J. Immunol., July 1, 2000; 165(1): 139 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wilson, L. C. Heffler, J. Charo, A. Scheynius, M.-T. Bejarano, and H.-G. Ljunggren Targeting of Human Dendritic Cells by Autologous NK Cells J. Immunol., December 15, 1999; 163(12): 6365 - 6370. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
